Trailing-twelve-month (TTM) revenue is $402.95 Million with a year-over-year growth of +30.67%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $92,299,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $118,470,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $109,531,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $82,648,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $402,948,000 |
Current P/S: $423,710,118 market capitalization ÷ $402,948,000 TTM revenue = 1.05x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:00:41.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $82.65M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:02:29.212Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Ancillary Revenue | $3M | N/A | N/A | N/A | N/A |
| Ancillary Revenue. | N/A | $100,000 | $11M | $15M | $49M |
$402.95M
$402.95 Million
+30.67%
vs. $308.37M a year ago (TTM)
+89.08%
5 Year compound annual growth rate
1 Year
+30.67%
3 Year
+52.46%
5 Year
+89.08%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $384.09M | +$127.26M | +49.55% |
| 2024 | $256.82M | +$95.87M | +59.57% |
| 2023 | $160.95M | +$106.36M | +194.85% |
| 2022 | $54.59M | +$32.37M | +145.74% |
| 2021 | $22.21M | +$9.16M | +70.24% |
| 2020 |
TTM Growth
+30.67%
3-Year CAGR
+52.46%
5-Year CAGR
+89.08%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:02:29.212Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Charging Revenue Commercial | $2M | N/A | $14M | $27M | $35M |
|---|
| Charging Revenue OEM | $812,000 | N/A | $5M | $16M | $26M |
|---|
| Charging Revenue Retail | $11M | N/A | $46M | $97M | $134M |
|---|
| Network Revenue OEM | N/A | N/A | $6M | $8M | $13M |
|---|
| Network Revenue, OEM | $2M | N/A | N/A | N/A | N/A |
|---|
| Regulatory Credit Sales | $3M | $6M | $7M | $9M | $10M |
|---|
| $13.05M |
| ($4.47M) |
| (25.53%) |
| 2019 | $17.52M | +$1.52M | +9.49% |
